Vivos Gross Profit from 2010 to 2024

VVOS Stock

USD 2.95 0.06 2.08%

Vivos Therapeutics Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Vivos Therapeutics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2019-09-30

Previous Quarter

2.7 M

Current Value

2.3 M

Quarterly Volatility

436 K

Covid

Check Vivos Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vivos Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 0.0 or Interest Income of 141.3 K, as well as many indicators such as Price To Sales Ratio of 1.04, Dividend Yield of 0.0 or PTB Ratio of 38.75. Vivos financial statements analysis is a perfect complement when working with Vivos Therapeutics Valuation or Volatility modules.

Check out the analysis of Vivos Therapeutics Correlation against competitors.

For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.

Latest Vivos Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Vivos Therapeutics over the last few years. Gross profit is a required income statement account that reflects total revenue of Vivos Therapeutics minus its cost of goods sold. It is profit before Vivos Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Vivos Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vivos Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 12.6 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Vivos Gross Profit Regression Statistics

	Arithmetic Mean	5,552,120
	Geometric Mean	4,513,189
	Coefficient Of Variation	67.38
	Mean Deviation	3,409,800
	Median	2,710,620
	Standard Deviation	3,741,150
	Sample Variance	14T
	Range	9.9M
	R-Value	0.81
	Mean Square Error	5.3T
	R-Squared	0.65
	Significance	0.0003
	Slope	673,498
	Total Sum of Squares	195.9T

Vivos Gross Profit History

	2024	9.5 M
	2023	7.7 M
	2022	10 M
	2021	12.6 M
	2020	10.4 M
	2019	8.7 M

Other Fundumenentals of Vivos Therapeutics

Gross Profit Margin

Vivos Therapeutics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.83	0.68	0.61	-0.92	-0.48	0.27	-0.59	0.72	-0.6	0.51	0.83	0.23	0.94	0.33	0.83	0.2	-0.75	0.66	0.38
Total Stockholder Equity	0.83		0.3	0.17	-0.97	-0.02	-0.16	-0.09	0.84	-0.09	0.04	0.99	-0.19	0.93	0.63	1.0	-0.05	-0.34	0.31	0.18
Net Tangible Assets	0.68	0.3		0.66	-0.41	-0.95	0.77	-0.82	0.02	-0.78	0.7	0.24	0.28	0.47	-0.2	0.27	-0.01	-0.85	0.95	0.77
Current Deferred Revenue	0.61	0.17	0.66		-0.37	-0.73	0.71	-0.92	0.34	-0.95	0.95	0.21	0.81	0.5	0.09	0.17	0.67	-0.94	0.74	0.43
Net Debt	-0.92	-0.97	-0.41	-0.37		0.17	0.0	0.3	-0.87	0.3	-0.25	-0.97	0.0	-0.99	-0.54	-0.97	-0.09	0.52	-0.45	-0.22
Retained Earnings	-0.48	-0.02	-0.95	-0.73	0.17		-0.91	0.9	0.15	0.85	-0.81	0.02	-0.49	-0.25	0.34	0.01	-0.16	0.85	-0.93	-0.8
Accounts Payable	0.27	-0.16	0.77	0.71	0.0	-0.91		-0.88	-0.19	-0.83	0.86	-0.18	0.63	0.11	-0.4	-0.19	0.34	-0.77	0.87	0.79
Long Term Debt	-0.59	-0.09	-0.82	-0.92	0.3	0.9	-0.88		-0.13	0.99	-0.97	-0.1	-0.75	-0.41	0.24	-0.08	-0.5	0.94	-0.88	-0.61
Net Receivables	0.72	0.84	0.02	0.34	-0.87	0.15	-0.19	-0.13		-0.18	0.19	0.9	0.17	0.88	0.7	0.86	0.42	-0.33	0.13	-0.08
Good Will	-0.6	-0.09	-0.78	-0.95	0.3	0.85	-0.83	0.99	-0.18		-0.98	-0.11	-0.79	-0.42	0.2	-0.09	-0.56	0.94	-0.83	-0.51
Total Liab	0.51	0.04	0.7	0.95	-0.25	-0.81	0.86	-0.97	0.19	-0.98		0.07	0.86	0.38	-0.14	0.03	0.67	-0.92	0.8	0.56
Net Invested Capital	0.83	0.99	0.24	0.21	-0.97	0.02	-0.18	-0.1	0.9	-0.11	0.07		-0.11	0.95	0.66	0.99	0.06	-0.34	0.27	0.13
Short Long Term Debt	0.23	-0.19	0.28	0.81	0.0	-0.49	0.63	-0.75	0.17	-0.79	0.86	-0.11		0.15	-0.12	-0.18	0.92	-0.63	0.41	0.27
Total Current Assets	0.94	0.93	0.47	0.5	-0.99	-0.25	0.11	-0.41	0.88	-0.42	0.38	0.95	0.15		0.55	0.93	0.24	-0.62	0.52	0.28
Capital Stock	0.33	0.63	-0.2	0.09	-0.54	0.34	-0.4	0.24	0.7	0.2	-0.14	0.66	-0.12	0.55		0.62	0.19	-0.05	-0.12	-0.11
Net Working Capital	0.83	1.0	0.27	0.17	-0.97	0.01	-0.19	-0.08	0.86	-0.09	0.03	0.99	-0.18	0.93	0.62		-0.03	-0.33	0.28	0.13
Short Term Debt	0.2	-0.05	-0.01	0.67	-0.09	-0.16	0.34	-0.5	0.42	-0.56	0.67	0.06	0.92	0.24	0.19	-0.03		-0.44	0.15	0.06
Intangible Assets	-0.75	-0.34	-0.85	-0.94	0.52	0.85	-0.77	0.94	-0.33	0.94	-0.92	-0.34	-0.63	-0.62	-0.05	-0.33	-0.44		-0.91	-0.61
Common Stock	0.66	0.31	0.95	0.74	-0.45	-0.93	0.87	-0.88	0.13	-0.83	0.8	0.27	0.41	0.52	-0.12	0.28	0.15	-0.91		0.82
Property Plant Equipment	0.38	0.18	0.77	0.43	-0.22	-0.8	0.79	-0.61	-0.08	-0.51	0.56	0.13	0.27	0.28	-0.11	0.13	0.06	-0.61	0.82

Click cells to compare fundamentals

About Vivos Therapeutics Financial Statements

Vivos Therapeutics shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Vivos Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Vivos Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Vivos Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	7.7 M	9.5 M
Gross Profit Margin	0.60	0.78

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Vivos Stock Analysis

When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC